Article
type: Class

Document
type: Class

A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds Against ERalpha Expressing Breast Cancer Cells
most specific type: Academic Article
type: Document
type: Academic Article
type: Article
type: Entity
type: Information Content Entity
type: Generically Dependent Continuant
type: Thing
type: Continuant
related by: 10246197

individual
rights: termsOfUse
date: 2026-08-24T04:04:37
publisher: A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds Against ERalpha Expressing Breast Cancer Cells
type: Document
label: RDF description of A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds Against ERalpha Expressing Breast Cancer Cells - http://irises.unilink.it/resource/item/22175

Information Content Entity
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

10246197
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds Against ERalpha Expressing Breast Cancer Cells

Generically Dependent Continuant
type: Class